Literature DB >> 12679915

Right trisectionectomy for primary liver cancer.

Jing-An Rui1, Shao-Bin Wang, Shu-Guang Chen, Li Zhou.   

Abstract

AIM: To evaluate the value of right trisectionectomy, previously named right trisegmentectomy, in the treatment of primary liver cancer by summarizing our 13-year experience for this procedure.
METHODS: Thirty three primary liver cancer patients undergoing right trisectionectomy from Apr. 1987 to Dec. 1999 were investigated retrospectively. The impacts in survival of patients by cancerous biological behavior, such as tumor thrombi and satellite nodules, were discussed respectively. All right trisectionectomies were performed under normothermic interruption of porta hepatis at single time. Ultrasonic dissector (CUSA system 200) was used in dissection of hepatic parenchyma from Nov. 1992, instead of finger fracture.
RESULTS: 1-, 3- and 5-year survival rates were 71.9 %, 40.6 % and 34.4 %, respectively. The longest survival term with free cancer was 150 months (alive). There were no significant differences in survival curves between cases with and without tumor thrombi (right branch of portal vein) and satellite nodules. Operative mortality was 3.0 % (1/33). Main surgical complications occurred in 5 cases.
CONCLUSION: Right trisectionectomy should be regarded as an effective and safe procedure for huge primary liver cancers and is worth using more widely.

Entities:  

Mesh:

Year:  2003        PMID: 12679915      PMCID: PMC4611433          DOI: 10.3748/wjg.v9.i4.706

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Hepatic resection for large hepatocellular carcinoma.

Authors:  K Hanazaki; S Kajikawa; N Shimozawa; K Shimada; M Hiraguri; N Koide; W Adachi; J Amano
Journal:  Am J Surg       Date:  2001-04       Impact factor: 2.565

2.  Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report.

Authors:  H Wakabayashi; S Okada; T Maeba; H Maeta
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.

Authors:  H Lau; K Man; S T Fan; W C Yu; C M Lo; J Wong
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

4.  Should hepatomas be treated with hepatic resection or transplantation?

Authors:  J Yamamoto; S Iwatsuki; T Kosuge; I Dvorchik; K Shimada; J W Marsh; S Yamasaki; T E Starzl
Journal:  Cancer       Date:  1999-10-01       Impact factor: 6.860

5.  Hepatic resection for hepatocellular carcinoma -- Japanese experience.

Authors:  M Makuuchi; T Takayama; K Kubota; W Kimura; Y Midorikawa; S Miyagawa; S Kawasaki
Journal:  Hepatogastroenterology       Date:  1998-08

6.  Is surgery for large hepatocellular carcinoma justified?

Authors:  J M Régimbeau; O Farges; B Y Shen; A Sauvanet; J Belghiti
Journal:  J Hepatol       Date:  1999-12       Impact factor: 25.083

7.  Cryosurgery of close or positive margins after hepatic resection for primary and metastatic hepatobiliary malignancies.

Authors:  Perry Shen; Aaron Hoffman; Russell Howerton; Brian W Loggie
Journal:  Am Surg       Date:  2002-08       Impact factor: 0.688

8.  Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC.

Authors:  G Pelletier; M Ducreux; F Gay; M Luboinski; H Hagège; T Dao; W Van Steenbergen; C Buffet; P Rougier; M Adler; J P Pignon; A Roche
Journal:  J Hepatol       Date:  1998-07       Impact factor: 25.083

9.  Right trisegmentectomy for hepatic neoplasms.

Authors:  T E Starzl; L J Koep; R Weil; J R Lilly; C W Putnam; J A Aldrete
Journal:  Surg Gynecol Obstet       Date:  1980-02

10.  [Hemihepatectomy under hepato-portal interruption at normal temperature for liver malignancies--a report of 20 patients].

Authors:  J G Rui; J Y Qu; Y Su; Z W Li; K Wang; G J Zhu; J X Wu; G J Chen; C F Wang; X W Mao
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1987-05
View more
  8 in total

1.  Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.

Authors:  Xin-Rong Liu; Rou-Li Zhou; Qing-Yun Zhang; Ye Zhang; Yue-Ying Jin; Ming Lin; Jing-An Rui; Da-Xiong Ye
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

2.  Techniques for liver parenchymal transection: a meta-analysis of randomized controlled trials.

Authors:  Viniyendra Pamecha; Kurinchi Selvan Gurusamy; Dinesh Sharma; Brian R Davidson
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

3.  Vascular clamping in liver surgery: physiology, indications and techniques.

Authors:  Elie K Chouillard; Andrew A Gumbs; Daniel Cherqui
Journal:  Ann Surg Innov Res       Date:  2010-03-26

4.  Liver trisectionectomies for primary and secondary liver cancer in the modern era: results of a single tertiary center.

Authors:  Nadia Russolillo; Alessandro Ferrero; Luca Viganò; Serena Langella; Marco Amisano; Lorenzo Capussotti
Journal:  Updates Surg       Date:  2010-12-16

5.  [Mesohepatectomy-an alternative to extended hepatectomy in the treatment of central liver tumors].

Authors:  H Lang; G C Sotiropoulos; N R Frühauf; A Radtke; M Malagó; Ch E Broelsch
Journal:  Chirurg       Date:  2004-03-12       Impact factor: 0.955

6.  Total vascular exclusion technique for resection of hepatocellular carcinoma.

Authors:  Zhen-Yu Yin; Xiao-Ming Wang; Ren-Xiang Yu; Bai-Meng Zhang; Ke-Ke Yu; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma.

Authors:  Li-Wu Lin; Xue-Ying Lin; Yi-Mi He; Shang-Da Gao; En-Sheng Xue; Xiao-Dong Lin; Li-Yun Yu
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

Review 8.  Current role of trisectionectomy for hepatopancreatobiliary malignancies.

Authors:  Philipp Kron; Norihisa Kimura; Shahid Farid; J Peter A Lodge
Journal:  Ann Gastroenterol Surg       Date:  2019-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.